Investors
Sustainable investing

Welcome to our dedicated space for forward-thinking investors.

Why invest in Novonesis?
Shaping a sustainable future

Novonesis is a pioneer in transformative biosolutions. Our biosolutions, including microbes, enzymes, and other proteins harness the potential of biology to feed and fuel the world more sustainably while enabling healthier lives.

Investing in Novonesis means contributing to a sustainable future through the power of biosolutions. Our commitment to leveraging the potential of biology for sustainable development positions us as a pioneering force in the industry. Join us in driving positive change and creating a better world for future generations.

The time for biosolutions is now

Biosolutions are already making a difference across over 30 different industries, promoting both healthier lives and a healthier planet.

With a rich history of over a century of innovation, we bring unparalleled technology and expertise to the forefront. Our collaborative approach allows us to identify opportunities, develop effective solutions, and ensure their successful implementation.

By leveraging our advanced biotech toolkit, industry knowledge, and global network, we are able to deliver high-quality biosolutions at scale.

Explore the era of biosolutions
Lab
image

Explore our ESG portal
People. Planet. Positive 

We exist to better our world with biology. Our sustainability ambition is to leave a positive impact on people and on the planet through our innovation, operations and employees. People. Planet. Positive.  

We are committed to delivering biosolutions that enable a healthier planet with healthier people. We call this positive impact on the world our handprint. Our biological products can help drive decarbonization, revitalize nature, enable healthy lives and transform food systems.

At the same time, we have high standards for reducing our footprint, the environmental impact of our production and supply chain and fostering an inclusive culture. 

Explore our ESG portal

Aligned with the UN Sustainable Development Goals

Sustainability is how we do business. It's at the core of who we are. And it's what we enable for our customers.

To expand our positive impact across more than 30 industries, we leverage nature’s own microbes, enzymes and proteins, together with decades of expertise. We document our contribution by assessing how our biosolutions align with the six UN Sustainable Development Goals (SDGs) most relevant to us. 

In 2025, >80% of our sales and biosolutions in our innovation pipeline are aligned* with at least one of the six selected SDGs.
 

SDG icons

ESG rankings & benchmarks

We are recognized for our commitment to sustainability by some of the world’s most respected ESG rating agencies, platforms and initiatives. 

  • CDP_Badges_2025_A_List_Climate_0.png

    CDP Climate Change & Water Security

    In 2026, Novonesis secured a position on CDP’s Climate Change A list. We also received a score of A- for CDP Water Security.

    Learn more
  • MSCI-Badge-AA-2025.png

    MSCI

    In 2025, we received a rating of AA (on a scale of AAA-CCC) in the MSCI ESG Ratings assessment.

    Learn more
  • sustainalytics logo

    Sustainalytics

    We secured a ‘Low Risk ESG Rating’ by Sustainalytics in 2025.

    Learn more
  • UNGC logo 2025

    UN Global Compact (UNGC)

    Since 2001, we have been a member of the UN Global Compact, a voluntary initiative based on CEO commitments to implement universal sustainability principles and to support UN SDGs.

    Learn more
  • FTSE 2025

    FTSE4Good

    We remained a constituent of the FTSE4Good Index Series in 2025

    Learn more
  • Ecovadis-gold-medal-July-2026-svg.png

    EcoVadis

    We have been awarded a Gold Medal and placed among the top 5% of companies assessed by EcoVadis in 2025

    Learn more

CDP: Please see our full response to CDP Corporate Questionnaire 2025. 

MSCI: The use by Novonesis of any MSCI ESG Research LLC or its affiliates (‘MSCI’) data, and the use of MSCI logos, trademarks, service marks or index names herein, do not constitute a sponsorship, endorsement, recommendation, or promotion of Novonesis by MSCI. MSCI services and data are the property of MSCI or its information providers and are provided ‘as-is’ and without warranty. MSCI names and logos are trademarks or service marks of MSCI. 

Sustainalytics: In August 2025, Novonesis received an ESG Risk Rating of 17.6 and was assessed by Morningstar Sustainalytics to be at Low risk of experiencing material financial impacts from ESG factors. In no event the information on this page and in our Annual Report 2025 shall be construed as investment advice or expert opinion as defined by the applicable legislation. The information contained or reflected herein is not directed to or intended for use or distribution to India-based clients or users and its distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect. 

EcoVadis: Please see our EcoVadis Recognition Page.

Reports and presentations

Explore our other investor-related pages

  • Company announcements

    Stay informed and keep up to date on company announcements. Don't forget to sign up for our notification alerts to receive these updates directly.

    Explore

  • Stock information

    Explore Novonesis' stock performance, ownership structure, the analysts covering Novonesis and the latest consensus.

    Explore

  • Results and events

    A quick overview of our upcoming financial announcements, shareholders’ meetings, and capital market days for easy access to our key financial dates and data

    Explore

  • Corporate governance

    We believe that proactive and transparent corporate governance promotes sustainable business behavior and long-term value creation

    Explore

* Each product and innovation project is evaluated annually for its documented impact towards SDGs 2, 3, 6, 7, 12 and 13. Sales assessment uses mapped benefits and supporting evidence of SDG alignment. Innovation assessment is based on expected outcomes of projects.